⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8728077 | 1.00 | — | — | |
| SCHEMBL5696710 | 0.75 | — | — | |
| SCHEMBL8468294 | 0.75 | — | — | |
| SCHEMBL120668 | 0.71 | — | — | |
| SCHEMBL20660 | 0.71 | — | — | |
| SCHEMBL55475 | 0.71 | — | — | |
| SCHEMBL1459636 | 0.69 | — | — | |
| SCHEMBL8734531 | 0.69 | — | — | |
| SCHEMBL1275981 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL11357998 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113795522-B | Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device | 三菱瓦斯化学株式会社 | 2022-08-12 | — | — | CN | disclosed |
| EP-4020652-A1 | ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE COMPRISING SAME | Ningde Amperex Technology Limited (CN) | 2022-06-29 | — | — | EP | disclosed |
| CN-114144467-A | Resin composition, resin sheet, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer, and semiconductor device | 三菱瓦斯化学株式会社 | 2022-03-04 | — | — | CN | disclosed |
| US-20210367268-A1 | ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE INCLUDING THE SAME | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2021-11-25 | — | — | US | disclosed |
| CN-112088430-A | Solid-state imaging element, solid-state imaging device, electronic apparatus, and method for manufacturing solid-state imaging element | 索尼公司 | 2020-12-15 | — | — | CN | disclosed |
| US-10570334-B2 | Liquid crystal compound, liquid crystal composition, composite material with encapsulated liquid crystal, and liquid crystal display device using same | JNC CORPORATION (JP) | 2020-02-25 | — | — | US | disclosed |
| US-20180051210-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, COMPOSITE MATERIAL WITH ENCAPSULATED LIQUID CRYSTAL, AND LIQUID CRYSTAL DISPLAY DEVICE USING SAME | JNC CORPORATION (JP) | 2018-02-22 | — | — | US | disclosed |
| US-9556161-B2 | Inhibitors of histone deacetylase | JANSSEN PHARMACEUTICA NV (BE) | 2017-01-31 | — | — | US | disclosed |
| US-9533979-B2 | Amino-derivatives as novel inhibitors of histone deacetylase | JANSSEN PHARMACEUTICA NV (BE) | 2017-01-03 | — | — | US | disclosed |
| EP-2324529-B1 | PROTON EXCHANGE MEMBRANE FOR USE IN PROTON EXCHANGE MEMBRANE FUEL CELLS | EWE FORSCHUNGSZENTRUM FÜR ENERGIETECHNOLOGIE E V (DE) | 2016-01-13 | — | — | EP | disclosed |
| EP-1011726-A2 | FUSED IMIDAZOLE DERIVATIVES FOR IMPROVING ORAL BIOAVAILABILITY OF PHARMACEUTICAL AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-06-28 | — | — | EP | disclosed |
| WO-1999013871-A2 | FUSED IMIDAZOLE DERIVATIVES FOR IMPROVING ORAL BIOAVAILABILITY OF PHARMACEUTICAL AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-03-25 | — | — | WO | disclosed |
| EP-0888352-A1 | FUSED IMIDAZOLE DERIVATIVES AS MULTIDRUG RESISTANCE MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-01-07 | — | — | EP | disclosed |
| WO-1998043649-A2 | AGE PRODUCTION INHIBITORY COMPOSITION COMPRISING A MAILLARD REACTION INHIBITOR AND VITAMIN B¿6? | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-08 | — | — | WO | disclosed |
| WO-1997034897-A1 | FUSED IMIDAZOLE DERIVATIVES AS MULTIDRUG RESISTANCE MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-09-25 | — | — | WO | disclosed |
| US-5422360-A | Hydrazonoimidazolidin-4-one derivatives; treatment of diabetes and aging disorders | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-06-06 | — | — | US | disclosed |
| EP-0531812-A1 | Maillard reaction inhibitor, process for producing it, composition containing it and the use thereof | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-03-17 | — | — | EP | disclosed |
| US-4746675-A | ENHANCED PENETRATION OF DRUG THROUGH SKIN OR MUCOSA | TEIJIN LIMITED (JP) | 1988-05-24 | — | — | US | disclosed |
| EP-0123948-B1 | EXTERNAL PHARMACEUTICAL COMPOSITION | TEIJIN LIMITED (JP) | 1987-09-30 | — | — | EP | disclosed |
| EP-0123948-A1 | External pharmaceutical composition | TEIJIN LIMITED (JP) | 1984-11-07 | — | — | EP | disclosed |